Validation of The Individualized Neuromuscular Quality of Life in Japanese patients with myotonic dystrophy

  • Fujino H
  • Saito T
  • Takahashi M
 et al. 
  • 4


    Mendeley users who have this article in their library.
  • 0


    Citations of this article.


© 2018 Wiley Periodicals, Inc. Introduction: The Individualized Neuromuscular Quality of Life (INQoL) is used to measure the quality of life (QoL) of patients with neuromuscular disease. We conducted this study to translate and validate the Japanese version of the INQoL in patients with myotonic dystrophy. Methods: Forward and backward translation, patient testing, and psychometric validation were performed. We used the 36-Item Short Form Health Survey (SF-36) and the modified Rankin scale for concurrent validation. Results: The Japanese INQoL was administered to 90 adult patients. The coefficients for internal consistency and test-retest reliability were adequately high in most domains (Cronbach α 0.88-0.96 and intraclass coefficient 0.64-0.99). INQoL domains were moderately to strongly associated with relevant SF-36 subscales (Spearman's ρ -0.23 to -0.74). Symptom severity, disease duration, employment status, and use of a ventilator influenced overall QoL. Discussion: The INQoL is a reliable and validated measure of QoL for Japanese patients with myotonic dystrophy.

Author-supplied keywords

  • INQoL
  • myotonic dystrophy
  • neuromuscular diseases
  • patient-reported outcome measures
  • quality of life
  • validation studies

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Toshio Saito

  • Masanori P. Takahashi

  • Hiroto Takada

  • Takahiro Nakayama

  • Katsuhisa Ogata

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free